
Tom Henderson - Ann Arbor-based Rubicon Genomics Inc., a maker of kits and reagents to increase the accuracy and speed of genomic analysis for gene-based research, drug development and diagnostics, announced Friday that it has agreed to be sold to Mountain View, Calif.-based Takara Bio USA Holdings Inc. in a $75 million deal expected to close next year. Takara Bio USA is a subsidiary of Takara Bio Inc., a leading global biotechnology and life science company based in Shiga, Japan. "This acquisition builds on
from Latest News - Crain's Detroit Business
Post a Comment